Previous 10 | Next 10 |
A Massachusetts-based %Biotech firm is grabbing the attention of traders across the board during Thursday’s premarket after it was announced that the company has entered into an exclusive license agreement with GSK ($GSK) for the company’s late-stage antibiotic asset, tebi...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Willy Barton / Shutterstock.com Spero Therapeutics (NASDAQ: SPRO ) stock is rocketing higher on Thursday after the company signed a licensing agreement with GSK (NYSE: GSK ). This deal covers the...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Shutterstock It’s time for an overview of the biggest pre-market stock movers that traders need to know about on Thursday! Moving stocks this morning is a licensing agreement, insider buying, and more...
GSK ( NYSE: GSK ) is acquiring a stake in Spero Therapeutics ( NASDAQ: SPRO ) as part of a licensing deal for the Cambridge, Mass.-based company's oral antibiotic to potentially treat complicated urinary tract infections (cUTI). Under the agreement...
The exclusive license allows GSK to commercialize tebipenem HBr in all territories, except Japan and certain other Asian countries Spero Therapeutics receives $66 million upfront, with potential for future milestone payments, and tiered royalties. GSK to purchase $9 mill...
Spero Therapeutics ( NASDAQ: SPRO ) has announced the appointment of Kamal Hamed, MD, MPH, MBA, as Chief Medical Officer. Before joining Spero, he was the CMO at Lysovant Sciences, a subsidiary of Roivant Sciences. Prior to his time at Lysovant, Dr. Hamed was Head of Clini...
CAMBRIDGE, Mass., Sept. 15, 2022 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO) today announced the appointment of Kamal Hamed, MD, MPH, MBA, as Chief Medical Officer (CMO). “Kamal joins Spero with an impressive track record of building and leading successful ...
3 Popular Penny Stocks to Add to Your Watchlist Right Now There are a number of reasons why finding popular penny stocks is important when it comes to making money in the stock market. For one, penny stocks that are popular tend to have more movement and therefore more liquidity tha...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Michael Vi / Shutterstock SoFi Technologies (NASDAQ: SOFI ) stock is on the move Wednesday as investors react to a multiyear contract with NFL player Justin Herbert. According to a press release from S...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Shutterstock Spero Therapeutics (NASDAQ: SPRO ) stock is climbing higher on Wednesday thanks to positive feedback from the FDA. That concerns plans to resubmit tebipenem HBr for the treatment of comp...
News, Short Squeeze, Breakout and More Instantly...
Spero Therapeutics Inc. Company Name:
SPRO Stock Symbol:
NASDAQ Market:
Spero Therapeutics Inc. Website:
CAMBRIDGE, Mass., June 03, 2024 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company, focused on identifying and developing novel treatments for rare diseases and multi-drug resistant (MDR) bacterial infections, today announced t...
CAMBRIDGE, Mass., May 16, 2024 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company, focused on identifying and developing novel treatments for rare diseases and multi-drug resistant (MDR) bacterial infections, today announced tha...
On track for topline data from SPR720 Phase 2a proof-of-concept trial in treatment-naive and treatment-experienced non-refractory NTM-PD patients, expected in 2H 2024 Enrollment ongoing in PIVOT-PO, a pivotal Phase 3 clinical trial of oral tebipenem HBr in cUTI Received FDA Fast...